GE Healthcare has acquired Biosafe Group, a supplier of integrated cell bioprocessing systems for the growing cell therapy and regenerative medicine industry for an undisclosed sum. The acquisition of Biosafe expands GE Healthcare’s end-to-end ecosystem of products, solutions and services for its cell therapy customers, and expands GE’s technology reach to a number of new cell and therapy types. Cellular therapies are changing the healthcare landscape by providing treatments for diseases, esp...